Epigenetic marks in Polycystic Ovary Syndrome

Volver a la Vista simple
dc.conicet.fuenteindividual
dc.conicet.organizacionConsejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos
dc.conicet.paisOrganizacionArgentina
dc.conicet.produccionid8467125
dc.contributor.authorMotta, Alicia Beatriz
dc.date.accessioned2020-12-10T16:42:07Z
dc.date.available2020-12-10T16:42:07Z
dc.date.issued2019-10
dc.date.updated2020-11-19T21:34:38Z
dc.description.abstractPolycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that affects women in their reproductive age. Recent studies have shown that genes have an important role in the etiology of PCOS. However, the precise way in which these genes are transcriptionally and post-transcriptionally regulated is poorly understood. The aim of the present review is to provide updated information on miRNAs and DNA methylation as epigenetic marks of PCOS. The data presented here allow concluding that both microRNAs and DNA methylation can be considered as possible useful biomarkers when choosing the treatment for a specific PCOS phenotype and thus represent two important tools for the diagnosis and treatment of PCOS patients.es
dc.description.filFil: Motta, Alicia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
dc.formatapplication/pdfes
dc.identifier.citationMotta, Alicia Beatriz; Epigenetic marks in Polycystic Ovary Syndrome; Bentham Science Publishers; Current Medicinal Chemistry; 26; 10-2019; 1-7es
dc.identifier.institucionalCONICET
dc.identifier.issn0929-8673es
dc.identifier.repoCONICET Digital
dc.identifier.urihttp://hdl.handle.net/11336/120111
dc.journal.ciudadOak Parkes
dc.journal.pagination1-7es
dc.journal.paisEstados Unidoses
dc.journal.titleCurrent Medicinal Chemistryes
dc.journal.volume26es
dc.language.isoenges
dc.publisherBentham Science Publisherses
dc.relation.alternativeidinfo:eu-repo/semantics/altIdentifier/url/https://pubmed.ncbi.nlm.nih.gov/31580245/
dc.relation.alternativeidinfo:eu-repo/semantics/altIdentifier/url/https://www.eurekaselect.com/175312/article
dc.rightsinfo:eu-repo/semantics/restrictedAccess*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/*
dc.subjectPOLYCYSTIC OVARY SYNDROMEes
dc.subjectEPIGENETIC MARKSes
dc.subjectDNA METHYLATIONes
dc.subjectmiRNAses
dc.subjectPCOS phenotypeses
dc.subject.classificationObstetricia y Ginecologíaes
dc.subject.classificationMedicina Clínicaes
dc.subject.classificationCIENCIAS MÉDICAS Y DE LA SALUDes
dc.titleEpigenetic marks in Polycystic Ovary Syndromees
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion

Archivos

Bloque original

Miniatura
Nombre:
CONICET_Digital_Nro.02a39696-92c2-4edc-9ccf-00dfe4a96451_A.pdf
Tamaño:
1.49 MB
Formato:
Adobe Portable Document Format
Solicitar

Colecciones

Articulos(CEFYBO)
Volver a la Vista simple